Corteva Inc

Corteva Inc

CTVA

Get informed when a big investor buys or sells

+ Follow
Market Cap$52.54B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Corteva IncCorteva Inc45.90.92%5%30.3

Earnings Call Q1 2026

May 6, 2026 - AI Summary

Strong Q1 fundamentals; confirms full-year 2026 guidance - Seed and Crop Protection delivered healthy double-digit EBITDA gains, with Corteva Q1 EBITDA up 21% YoY and 200+ bps margin expansion. - Organic sales +7% YoY: Seed +9%, Crop Protection +4% (currency tailwind ~+4%). - Operating EBITDA margin >29% (up ~240 bps), driven by price/mix, volume, cost savings/productivity, partially offset by spending headwinds. - Reaffirmed 2026 outlook: Operating EBITDA $4.0B–$4.2B (margin 22%–23%) and Operating EPS $3.45–$3.70 (~7% growth at midpoint).
What to watch in the year: “second-half risks” are real but controllable - Management says Q1 is ahead of expectations and “first half playing out a little better than expected,” but agriculture is seasonal so they won’t reset guidance in May (plan: assess after Q2). - Farmer behavior / acreage assumptions in guidance: - US corn acreage expected to decline ~3%–4% as planted area shifts toward soybeans. - Enlist beans projected at ~65% penetration of US soybean acres in 2026 (Enlist is described as the #1 soybean technology in the US as it matures). - Crop protection market assumed modest growth globally (low single-digit volume gains with slightly negative pricing); Corteva expects mid single-digit volume gains more than offset by low single-digit pricing headwinds.
Growth/strategy opportunities: royalty-positive inflection + technology pipeline - Seed is progressing toward becoming royalty-positive later this year: Q1 included another ~$30M decrease in net royalty expense (driven by lower royalty on certain Enlist traits). - ~100+ independent seed company licensees for PowerCore and Enlist Corn / Enlist E3 soybeans (supporting share gains and margins). - Separation creates an “optionality” narrative: the seed/genetics pure-play is named Vylor (significant longer-term pipeline, including hybrid wheat launching next year and broader biotech/gene-editing opportunities). - CP opportunity highlights: expectation of ~7 new active ingredients plus biologicals rollouts; management cites upcoming biocontrol as an industry “first” style product.

Exclusive for Stockcircle Pro members

Sign upSign Up
$90.83

Target Price by Analysts

15.2% upsideCorteva Target Price DetailsTarget Price
$154.05

Current Fair Value

95.4% upside

Undervalued by 95.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$52.54 Billion
Enterprise Value$56.94 Billion
Dividend Yield$0.72 (0.92%)
Earnings per Share$1.61
Beta0.57
Outstanding Shares672,500,000

Return

Return on Equity4.77%ROE
Return on Assets2.72%
Return on Invested Capital5.67%

Valuation & Multiples

P/E Ratio45.94P/E Ratio
PEG440.5PEG
Price to Sales3.03Price to Sales
Price to Book Ratio2.19Price to Book Ratio
Enterprise Value to Revenue3.18
Enterprise Value to EBIT32.55
Enterprise Value to Net Income48
Total Debt to Enterprise0.11
Debt to Equity0.26Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 6, 2026
EPS Estimate
$1.13
Average shareholder expectation
Revenue Estimate
$4.64 B
Average shareholder expectation

Next Earnings Call

Expected Date
July 30, 2026
EPS Estimate
$2.22
Average shareholder expectation
Revenue Estimate
$6.57 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.2415 15.36%
Total Calls1,023,900 93.55%
Total Puts247,248 18.30%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %86.09% 0.19%
Total Invested$48.39B 24.84%
Investors Holding1,496 59.00%

ESG Score

No data

About Corteva Inc

21,000 employees
CEO: James Collins

Corteva Agriscience is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry - including a balanced and diverse mix of seed, crop protection and di...

Relevant Senate Committees

Joint Committee on Taxation

This committee's analysis and scoring of tax legislation directly influences corporate tax structures, R&D credits, and the overall tax burden, significantly impacting Corteva's financial planning and investment decisions.

Finance

This powerful committee controls taxation and trade policy, both of which are critical for Corteva's global operations, impacting corporate profitability through tax rates and market access through international trade agreements and tariffs.

Appropriations

This committee allocates discretionary federal spending, including funding for agricultural research, conservation programs, and farmer support, which directly impacts Corteva's potential R&D opportunities and its customers' financial stability.

Agriculture, Nutrition, and Forestry

This is the primary committee for agriculture, directly overseeing the Farm Bill which impacts farmer subsidies, crop insurance, and conservation programs, thereby directly influencing demand for Corteva's products and services. It also regulates commodity markets.

Judiciary

This committee's oversight of antitrust laws and intellectual property is crucial for Corteva, impacting potential mergers and acquisitions, and protecting its extensive portfolio of seed genetics and crop protection technologies.

Environment and Public Works

This committee regulates the EPA, which sets critical standards for pesticides, fertilizers, and other crop protection chemicals that Corteva manufactures, directly impacting product development, approval, and operating costs.

Foreign Relations

As a global company, Corteva is heavily impacted by U.S. foreign policy, international trade agreements, and sanctions that affect market access, supply chains, and global demand for agricultural products.